News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
李氏大藥廠(00950.HK)茵若颯取得國家藥監局批准
李氏大藥廠(00950.HK)公布，中國國家藥品監督管理局已批准茵若颯用於治療具有中重度症狀(不包括泌尿系症狀)的絕經後女性外陰陰道萎縮。茵若颯由Cosette Pharmaceuticals擁有並已授李氏大藥廠許可。(de/d)~阿思達克財經新聞網址: www.aastocks.com
Reset
Send
The window will close in 5 seconds
李氏大藥廠(00950.HK)茵若颯取得國家藥監局批准
Close
Recommend
1
Positive
1
Negative
0
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

李氏大藥廠(00950.HK)  -0.030 (-2.419%)   公布，中國國家藥品監督管理局已批准茵若颯用於治療具有中重度症狀(不包括泌尿系症狀)的絕經後女性外陰陰道萎縮。茵若颯由Cosette Pharmaceuticals擁有並已授李氏大藥廠許可。(de/d)(HK stocks quote is delayed for at least 15 mins.)

AASTOCKS新聞

Switch to Auto-Translated Version
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.